Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cholesterol
5
×
life sciences
national blog main
national top stories
new york blog main
5
×
new york top stories
amgen
boston blog main
boston top stories
inclisiran
praluent
regeneron pharmaceuticals
repatha
biotech
ldl
new york
pcsk9
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cardiovascular
clinical trials
david maron
detroit blog main
detroit top stories
heart disease
indiana blog main
indiana top stories
medco
medicines co.
mt sinai hospital
national
prashant vaishnava
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
What
cholesterol
drug
lowering
big
medco
medicines
twice
abbvie’s
abuzz
aces
ago
amarin
announced
barbecuing
bio
bringing
camping
cardiologist
center
ceo
check
clears
clinical
closer
community
conference
day
deeper
dive
doctors
drugs
eager
expensive
faces
fda
filing
financial
fish
flexible
flop
Language
unset
Current search:
cholesterol
×
" new york blog main "
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder